Two Smaller Companies Worthy of Your “Attention”
Elite Pharmaceuticals Inc. (ELTP) fits nicely into the nexus of the increasing diagnoses of ADHD and the patent expiration of the branded drug Vyanse in ...
Read moreLook Forward, Move Forward – Reporting on the cutting edge developments leading the way.
Elite Pharmaceuticals Inc. (ELTP) fits nicely into the nexus of the increasing diagnoses of ADHD and the patent expiration of the branded drug Vyanse in ...
Read moreNvidia Corporation‘s (NASDAQ: NVDA) shares dipped 3.4% in response to its fiscal 2025 third-quarter results last week, but I see this modest move lower as ...
Read moreVolkswagen VLKAF has boosted its initial investment in American electrical vehicle (EV) maker Rivian RIVN to $5.8 billion, $800 million more than initially planned. The ...
Read moreTom Yeung here with this week’s Sunday Digest. Many of you will know that I am a relatively conservative investor. I pay close attention to ...
Read moreGlancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming January 7, 2025 deadline to file a lead plaintiff motion in the class action ...
Read moreNVIDIA Corp NVDA investors have no shortage of reasons to continue bidding up NVDA stock. Primarily, the semiconductor stalwart — known for its advanced graphics ...
Read moreIn recent trading, shares of Kyndryl Holdings Inc (Symbol: KD) have crossed above the average analyst 12-month target price of $32.75, changing hands for $33.05/share. ...
Read moreHere are five stocks added to the Zacks Rank #1 (Strong Buy) List today: Donegal Group Inc. DGICA: This insurance holding company has seen the ...
Read moreNvidia (NASDAQ: NVDA) did it again. The AI chip superstar delivered another round of smashing results, easily beating estimates in its third-quarter earnings report on ...
Read moreOn the surface, Boeing (NYSE: BA) looks as though it has all the ingredients of a potential millionaire-maker investment. The aircraft market is growing, competition ...
Read more